SEARCH

SEARCH BY CITATION

References

  • 1
    Centers for Disease Control and Prevention. Health information for international travel 2008. Atlanta: US Department of Health and Human Services, Public Health Service, 2007.
  • 2
    Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Morb Mortal Wkly Rep 2000; 49(RR-10): 99.
  • 3
    Committee to Advise on Tropical Medicine and Travel (CATMAT). The immunocompromised traveler. Can Commun Dis Rep 2007; 33(ACS-4): 124.
  • 4
    Ljungman P, Engelhard D, De La Camara R, et al. for the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005; 35: 737746.
  • 5
    Singhal S, Mehta J. Reimmunization after blood or marrow stem cell transplantation. Bone Marrow Transplant 1999; 23: 637646.
  • 6
    Kotton CN, Ryan ET, Fishman JA. Prevention of infection in adult traveler after solid organ transplantation. Am J Transplant 2005; 5: 814.
  • 7
    Gowda R, Cartwright K, Bremner JAG, et al. Yellow fever vaccine: a successful vaccination of an immunocompromised patient. Eur J Haematol 2004; 72: 299301.
  • 8
    Receveur MC, Thiebaut R, Vedy S, et al. Yellow fever vaccination of human immunodeficiency virus infected patients: report of two cases. Clin Infect Dis 2000; 31: e7e8.
  • 9
    Kengsakul K, Sathirapongsasuti K, Punyagupta S. Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection. J Med Assoc Thai 2002; 85: 131134.
  • 10
    Monath TP. Yellow fever vaccine. In: PlotkinS, OrenstienW, eds. Vaccines. 4th ed. Phila: WB Saunders, 2003; 1095176.
  • 11
    Barwick RE. History of thymoma and yellow fever vaccination. Lancet 2004; 364: 936.
  • 12
    Vasconcelos PFC, Luna EJ, Galler R, et al. Brazilian Yellow Fever Vaccine Evaluation Group. Serious adverse events associated with yellow fever 17D vaccine in Brazil: report of two cases. Lancet 2001; 358: 9197.
  • 13
    Martins RM, Galler R, Freire MS, et al. Letter to the editor: yellow fever vaccination: some thoughts on how much is enough. Vaccine 2007; 25: 1011.
  • 14
    Massad E, Coutinho FAB, Burattini MN, et al. Yellow fever vaccination: how much is enough? Vaccine 2005; 23: 39083914.
  • 15
    Khromava AY, Eidex RB, Weld LH, et al. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. Vaccine 2005; 23: 32563263.